Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
11:15 | Dividendenbekanntmachungen (15.05.2025) | 734 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 1&1 AG DE0005545503 - 0,05 EUR 1ST SOURCE CORPORATION US3369011032 0,38 USD EUR ABBVIE INC US00287Y1091 1,64 USD EUR ADF GROUP... ► Artikel lesen | |
Mi | Trendwende bei BioNTech schon am Freitag? Steigt die Aktie jetzt bald um 43%? | 548 | BÖRSE ONLINE | Die abgestürzte Aktie des Mainzer Biotech-Unternehmens BioNTech könnte am Freitag neue Impulse für eine Trendwende bekommen. Sind dann auch zweistellige Kurssprünge drin? Von der Marke von 100 Euro... ► Artikel lesen | |
Mi | Aktienmarkt: Kurs der Amgen-Aktie im Minus (234,3972 €) | 363 | ARIVA.de | Im US-amerikanischen Wertpapierhandel notiert die Amgen-Aktie zur Stunde ein wenig leichter. Zuletzt zahlten Investoren für die Aktie 262,26 US-Dollar. Für Inhaber von Amgen ist der heutige Handelstag... ► Artikel lesen | |
Mi | Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025 | 294 | GlobeNewswire (Europe) | Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise, with key data readouts expected this year
ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy... ► Artikel lesen | |
Mi | Leichter Wertverlust bei der Moderna-Aktie (21,7192 €) | 281 | ARIVA.de | Die Aktie von Moderna notiert am Mittwoch ein wenig leichter. Die Aktie kostete zuletzt 24,34 US-Dollar. An der Börse liegt der Anteilsschein von Moderna derzeit im Minus. Das Wertpapier verbilligte... ► Artikel lesen | |
Mi | Viatris-Aktie mit Kursverlusten (7,55567 €) | 270 | ARIVA.de | Die Aktie von Viatris notiert am Mittwoch etwas leichter. Der jüngste Kurs betrug 8,47 US-Dollar. Heute hat sich am US-amerikanischen Aktienmarkt die Viatris-Aktie zwischenzeitlich um 3,64 Prozent verbilligt.... ► Artikel lesen | |
Mi | Galapagos NV: Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101 | 232 | GlobeNewswire (Europe) | Mechelen, Belgium; May 14, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation... ► Artikel lesen | |
Mi | Genmab A/S: Genmab to Present New and Updated Results from its Robust Epcoritamab (EPKINLY) Development Program at the 2025 European Hematology Association (EHA) Congress | 222 | Business Wire | Data from 14 abstracts highlight the depth, breadth, and strength of Genmab's comprehensive epcoritamab development program across multiple patient populations and treatment settings Genmab... ► Artikel lesen | |
Mi | BeiGene, Ltd.: BeiGene Showcases Strength of Hematology Portfolio at EHA 2025 with New Data Highlighting BRUKINSA's Leadership and Next-Generation Innovation | 208 | Business Wire | Data across 31 abstracts illustrate BeiGene's deep commitment to transforming treatment for B-cell malignancies Four oral presentations highlight updated data from investigational BTK protein... ► Artikel lesen | |
Mi | Cascale Talks ESPR at Innovation Forum Sustainable Apparel Event in Amsterdam | 174 | ACCESS Newswire | NORTHAMPTON, MA / ACCESS Newswire / May 14, 2025 / Elisabeth von Reitzenstein, senior director of policy and public affairs at Cascale, recently took to the stage at Innovation Forum's Sustainable Apparel... ► Artikel lesen | |
Mi | Nkarta, Inc.: Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights | 97 | GlobeNewswire (Europe) | Enrollment open in investigator-sponsored trial (IST) of NKX019 in myasthenia gravis; Ntrust-1, Ntrust-2, and IST of NKX019 in systemic lupus erythematosus remain open to enrollment Ntrust-1 expanded... ► Artikel lesen | |
Mi | Kura Oncology, Inc.: Kura Oncology and Kyowa Kirin Announce Combination Data for Ziftomenib in Oral Presentation at the 2025 European Hematology Association (EHA) Congress | 80 | GlobeNewswire (Europe) | - Ziftomenib combined with 7+3 in 1L NPM1-m or KMT2A-r AML patients selected for oral presentation on Thursday, June 12th - - Updated dataset to be presented in oral presentation at EHA2025 Congress... ► Artikel lesen | |
Mi | Ultragenyx Pharmaceutical Inc.: Ultragenyx Underscores Continued Commitment to Rare Disease Innovation with 2024 Impact Report | 62 | GlobeNewswire (Europe) | NOVATO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) released its 2024 Impact Report today, which covers the company's approach to corporate responsibility.... ► Artikel lesen | |
Mi | Editas Medicine, Inc.: Editas Medicine Reports New In Vivo Data Highlighting the Potential of Editas' Gene Upregulation Strategy in HSCs at the American Society of Gene and Cell Therapy Annual Meeting | 55 | GlobeNewswire (Europe) | Data demonstrate therapeutically relevant editing levels using a clinically validated strategy, supporting its development as a novel, in vivo approach to treating sickle cell disease and beta thalassemia... ► Artikel lesen | |
05:00 | Mesoblast Limited: FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil | 45 | GlobeNewswire (Europe) | NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received seven years... ► Artikel lesen |
Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
---|---|---|---|---|---|---|
VIATRIS | 7,536 | 0,00 | 0,00 % | |||
LIGAND PHARMACEUTICALS | 97,00 | 0,00 | 0,00 % | |||
REGENERON PHARMACEUTICALS | 515,00 | 0,00 | 0,00 % | |||
IONIS PHARMACEUTICALS | 28,870 | 0,00 | 0,00 % | |||
GILEAD SCIENCES | 87,98 | 0,00 | 0,00 % | |||
BIOGEN | 107,90 | 0,00 | 0,00 % | |||
INNOVIVA | 15,900 | 0,00 | 0,00 % | |||
SIGA TECHNOLOGIES | 5,940 | 0,00 | 0,00 % | |||
GRIFOLS | 8,638 | 0,00 | 0,00 % | |||
BIONTECH | 82,60 | 0,00 | 0,00 % |
Aktien WKN | Akt. Kurs Vortag | +/- % | Zeit | ||
---|---|---|---|---|---|
10X GENOMICS INC A2PPQJ Tradegate | 8,560 8,170 | +0,390 +4,77 % | 09:31 | ||
4D MOLECULAR THERAPEUTICS INC A2PS5P NASDAQ | 3,150 3,260 | 0,000 0,00 % | 14.05. | ||
89BIO INC A2PUP8 NASDAQ | 8,190 7,805 | 0,000 0,00 % | 14.05. | ||
ABCELLERA BIOLOGICS INC A2QKXS Tradegate | 1,878 1,841 | +0,038 +2,04 % | 11:01 | ||
ABSCI CORPORATION A3CVW3 NASDAQ | 2,910 2,950 | 0,000 0,00 % | 14.05. | ||
AC IMMUNE SA A2AR5F Tradegate | 1,390 1,424 | +0,010 +0,72 % | 14.05. | ||
ACADIA PHARMACEUTICALS INC 603035 Tradegate | 15,845 15,800 | +0,480 +3,12 % | 13.05. | ||
ACELYRIN INC A3EDH4 NASDAQ | 2,045 2,080 | 0,000 0,00 % | 14.05. | ||
ACRIVON THERAPEUTICS INC A3DXE7 NASDAQ | 1,155 1,130 | 0,000 0,00 % | 14.05. | ||
ADAPTIVE BIOTECHNOLOGIES CORPORATION A2PLR5 Tradegate | 8,360 8,582 | +0,270 +3,34 % | 13.05. |